Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationTransplantation ConditioningTransplantation, HomologousHematopoietic Stem Cell MobilizationBone Marrow TransplantationGraft vs Host DiseaseGranulocyte Colony-Stimulating FactorLeukapheresisMelphalanAntigens, CD34Combined Modality TherapyBlood Component RemovalMultiple MyelomaHematologic NeoplasmsTreatment OutcomeCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem CellsBusulfanLymphoma, Non-HodgkinMyeloablative AgonistsGraft SurvivalRecurrenceThiotepaEtoposideHodgkin DiseaseStem Cell TransplantationStem CellsAntineoplastic Agents, AlkylatingCytophagocytosisRemission InductionCarmustineSalvage TherapyIfosfamideImmunosuppressive AgentsRetrospective StudiesVincristineHematopoiesisCytarabineNeoplasmsAmyloidosisSurvival AnalysisDisease-Free SurvivalTissue DonorsSurvival RateTime FactorsBlood Cell CountBone Marrow PurgingDoxorubicinBlood Transfusion, AutologousLymphoma, T-CellCarboplatinCytomegalovirus InfectionsDexamethasoneWhole-Body IrradiationCord Blood Stem Cell TransplantationPlatelet CountRecombinant ProteinsPrednisoneBlood CellsInfectionHistocompatibilityFollow-Up StudiesAntineoplastic AgentsHistocompatibility TestingProspective StudiesLeukocytes, MononuclearTransplantation ChimeraLeukemia, Myeloid, AcuteTransplantationFatal OutcomeLymphomaT-LymphocytesFeasibility StudiesCell SeparationLeukemiaKidney TransplantationOpportunistic InfectionsImmunophenotypingFlow CytometryBlood DonorsImmunocompromised HostFeverVidarabineImmunomagnetic SeparationBreast NeoplasmsCells, CulturedHematologic DiseasesAnemia, AplasticCyclosporineGranulocyte-Macrophage Colony-Stimulating FactorEmbryonic Stem CellsTransplantsTransplantation, IsogeneicLymphocytesAdult Stem CellsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte Depletion